Barry Fishman
Director/Board Member chez FIELD TRIP HEALTH & WELLNESS LTD.
Fortune : - $ au 31/03/2024
Profil
Barry Fishman currently works at Sequoia Advisors, Inc., as Managing Director from 2014, Juno Pharmaceuticals Corp., as Director, Field Trip Health & Wellness Ltd., as Independent Director, Reunion Neuroscience, Inc., as Lead Independent Director from 2021, Algae-C, Inc., as Director & Head-Pharmaceuticals, Medicus Pharma Ltd., as Independent Director from 2023, and Apotex, Inc., as Chief Corporate Development Officer.
Mr. Fishman also formerly worked at Norgine BV, as Chief Executive Officer, Teva Canada Ltd., as Chief Executive Officer from 2003 to 2013, Merus Labs International, Inc., as Chief Executive Officer in 2017, Taro Pharmaceuticals, Inc., as Chief Executive Officer from 2000 to 2003, VIVO Cannabis, Inc., as Chief Executive Officer & Director from 2017 to 2020, The Canadian Generic Pharmaceutical Association, as Chairman, Aurora Cannabis, Inc., as Independent Director from 2016 to 2017, Advanz Pharma Corp.
Ltd., as Independent Director from 2018 to 2020, Canopy Growth Corp., as Independent Director from 2014 to 2016, Bedrocan Cannabis Corp., as Independent Director, Akerna Corp., as Independent Director from 2021 to 2023, Field Trip Health Ltd., as Lead Director, Eli Lilly Canada, Inc., as Vice President-Marketing from 1983 to 2000, and Deloitte Development LLC, as Senior Associate from 1979 to 1982.
Mr. Fishman received his undergraduate degree from McGill University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 24/10/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Barry Fishman
| Sociétés | Poste | Début |
|---|---|---|
| FIELD TRIP HEALTH & WELLNESS LTD. | Director/Board Member | - |
Juno Pharmaceuticals Corp.
 Juno Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022. | Director/Board Member | - |
Algae-C, Inc.
 Algae-C, Inc. BiotechnologyHealth Technology Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then. | Director/Board Member | - |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Director/Board Member | 01/06/2021 |
| Sequoia Advisors, Inc. | Corporate Officer/Principal | 01/02/2014 |
Apotex, Inc.
 Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Anciens postes connus de Barry Fishman
| Sociétés | Poste | Fin |
|---|---|---|
| GRYPHON DIGITAL MINING, INC. | Director/Board Member | 15/11/2023 |
| VIVO CANNABIS INC. | Chief Executive Officer | 31/12/2020 |
| ADVANZ PHARMA CORP. LIMITED | Director/Board Member | 01/01/2020 |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Barry Fishman
| McGill University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AURORA CANNABIS INC. | Process Industries |
| CANOPY GROWTH CORPORATION | Process Industries |
| FIELD TRIP HEALTH & WELLNESS LTD. | Health Services |
 | Health Technology |
| Entreprise privées | 16 |
|---|---|
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The private company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Health Technology |
Apotex, Inc.
Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | Health Technology |
The Canadian Generic Pharmaceutical Association
 The Canadian Generic Pharmaceutical Association Pharmaceuticals: GenericHealth Technology The Canadian Generic Pharmaceutical Association provides generic prescription medicines and active pharmaceutical ingredients. The company was founded in 1984 and is headquartered in Toronto, Canada. | Health Technology |
Norgine BV
 Norgine BV Pharmaceuticals: MajorHealth Technology Norgine BV engages in development and manufacture of pharmaceutical products. It is specialized in gastroenterology, hepatology, cancer, and supportive care. The firms brands include Depoint, Elantan, Emselex, Estraderm, Givalex, Isoket, Nortussine, Provames, Sintrom, Speciafoldine, Surgestone, and Tredemine. The company was founded by Victor Stein in 1906 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Deloitte Development LLC
 Deloitte Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte Development LLC provides legal and auditing services. The private company is based in New York, NY. | Commercial Services |
Teva Canada Ltd.
 Teva Canada Ltd. Pharmaceuticals: GenericHealth Technology Part of Teva Pharmaceutical Industries Ltd., Teva Canada Ltd. is a Canadian company that deeply cares about the wellbeing of patients, caregivers, and communities. The private company serves 200 million people every day, offering a unique perspective on health through their leadership in generic and brand-name medicines, as well as innovative solutions for healthcare partners. The company is based in Toronto, Canada. Sandy Lee's journey with Teva started in 1988 when she accepted a position as a secretary in Teva's regulatory affairs department. | Health Technology |
Merus Labs International, Inc.
 Merus Labs International, Inc. Pharmaceuticals: MajorHealth Technology Merus Labs International, Inc. wass a pharmaceutical company. It was engaged in the acquisition of mature prescription and over the counter pharmaceutical products and licensing in of novel hospital products. The company was founded by Ahmad Doroudian on December 19, 2011 and it was headquartered in Vancouver, Canada. | Health Technology |
Taro Pharmaceuticals, Inc.
 Taro Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Taro Pharmaceuticals, Inc. manufacturer and supplier of topical dermatological products. It’s products includes Taro Rx and Taro OTC. It develops creams ointments and gels and also have a growing line of solid dosage from products. It’s customer includes wholesalers, drugstore chains, mass volume retailers, healthcare institutions, independent drug stores and discount retailers. The company was founded in 1950 and is headquartered in Brampton, Canada. | Health Technology |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
Bedrocan Cannabis Corp.
 Bedrocan Cannabis Corp. Pharmaceuticals: OtherHealth Technology Bedrocan Cannabis Corp. produces, imports, and distributes pharmaceutical-grade medicinal cannabis to patients in Canada. Its products include Bedropuur, a tetrahydrocannibinol (THC) indica for THC extraction; Bedrocan, a sativa plant type cannabis; Bedica, an indica dominant strain of cannabis; and Bediol, Bedrolite, and Bedrobinol products, which are sativa dominant strains of cannabis. The company was founded by Murray Goldman and Marc Wayne on February 24, 2012 and is headquartered in Toronto, Canada. | Health Technology |
| Sequoia Advisors, Inc. | |
VIVO Cannabis, Inc.
 VIVO Cannabis, Inc. Agricultural Commodities/MillingProcess Industries VIVO Cannabis, Inc. is a capital pool company, which engages in the production, sales, and research licenses from Health Canada; and operates indoor cultivation facilities. It operates through the following segments: Craft Cannabis Product, Medical Cannabis Clinic, and Corporate and International. The Craft Cannabis Product segment focuses on producing and selling cannabis and cannabis-derived products for direct sale to medical patient and for the adult-use market. The Medical Cannabis Clinic segment is involved and operated by its indirect wholly-owned subsidiary, Harvest Medicine Inc. The Corporate segment includes non-production related corporate activities and international operations. The company was founded by Ken Clement on April 12, 2007 and is headquartered in Toronto, Canada. | Process Industries |
Akerna Corp.
 Akerna Corp. Data Processing ServicesTechnology Services Akerna Corp. engages in the provision of software as a service solutions within the cannabis industry that enable regulatory compliance and inventory management. The firm also provides project-focused consulting services to clients who are initiating or expanding their cannabis business operations or are interested in data consulting engagements. The company was founded on June 17, 2019 and is headquartered in Denver, CO. | Technology Services |
Juno Pharmaceuticals Corp.
Juno Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022. | Health Technology |
Field Trip Health Ltd.
 Field Trip Health Ltd. Medical/Nursing ServicesHealth Services Field Trip Health Ltd. engages in development and delivery of technology-enabled psychedelic therapies. It offers psychedelic-enhanced and psychedelic-integration psychotherapy. The firm is developing patient-centric and evidence-based psychedelic approaches to behavioral and mental health. The company was founded by Joseph del Moral, Ronan Levy, Hannan Fleiman, Syed Mujeeb Jafferi, and Ryan Yermus on September 30, 2008 and is headquartered in Toronto, Canada. | Health Services |
Algae-C, Inc.
Algae-C, Inc. BiotechnologyHealth Technology Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then. | Health Technology |
